 |
 |
 |
 |
 |
|
|
|
|
|
 |
|
|
||
|
 |
 |
||
|
|
Atypical antipsychotics Because of the greater risk of side effects, particularly dystonic reactions in adolescents most people have enthusiastically changed to the atypical anti-psychotics (risperidone, olanzepine etc) because of a belief that they are less toxic in this way. However, balancing this is the increased risk of weight gain and in particular Type 2 diabetes. There is increasing evidence that the newer anti-psychotics offer no significant advantage over their older cheaper predecessors (haloperidol, etc).
There is no unequivocal right answer. It is currently a case of matching the side effect profile with the patients needs. Always seek out independent sopurces of information such as the Australian Medicines Handbook:
| |
|
|
 |
 |
||
|
